Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
World Lupus Federation Global Survey Finds 91% of People with Lupus Report Using Oral Steroids to Treat Lupus 2024-05-06 08:00
VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure 2024-05-04 18:00
United Imaging to Unveil Industry-Leading MRI Advancements at ISMRM 2024 2024-05-04 09:00
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease 2024-05-03 19:00
Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success 2024-05-02 15:00
Vivo Surgical Announces Leading Gastrointestinal Endoscopists on Clinical Advisory Board for Novel Endoscopic Robot 2024-05-02 10:00
Everest Medicines Announces Hong Kong Department of Health Approval of Nefecon® for the Treatment for Primary IgA Nephropathy in Adult Patients 2024-05-02 09:23
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers 2024-05-02 07:01
United Imaging Receives FDA Clearance for Breakthrough 5T MRI System 2024-05-02 03:00
3Shape Unveils Unite 3rd Generation: Access TRIOS Scans Anywhere, Anytime 2024-05-01 21:43
Neogen® Petrifilm® Celebrates 40 Years! 2024-05-01 20:45
ArisGlobal Helps Boehringer Ingelheim Transform Safety Signal Processing by Leveraging Latest LifeSphere Solutions 2024-05-01 20:00
135th Canton Fair Showcases Leading Medical Devices, Elevating Global Health Management 2024-05-01 13:40
Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint 2024-05-01 08:59
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers 2024-05-01 08:01
Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) - and Upcoming Scientific Presentations 2024-04-30 23:00
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma 2024-04-30 20:55
A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs 2024-04-30 20:16
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia 2024-04-30 19:00
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update 2024-04-30 19:00
1 69 70 71 72 73 962